| 000 | 01649 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512211908.0 | ||
| 264 | 0 | _c19840823 | |
| 008 | 198408s 0 0 eng d | ||
| 022 | _a0022-5347 | ||
| 024 | 7 |
_a10.1016/s0022-5347(17)49582-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKurth, K H | |
| 245 | 0 | 0 |
_aAdjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alone. _h[electronic resource] |
| 260 |
_bThe Journal of urology _cAug 1984 |
||
| 300 |
_a258-62 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDoxorubicin _xadverse effects |
| 650 | 0 | 4 |
_aEthers _xtherapeutic use |
| 650 | 0 | 4 |
_aEthoglucid _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMethods |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aUrethra |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
| 700 | 1 | _aSchröder, F H | |
| 700 | 1 | _aTunn, U | |
| 700 | 1 | _aAy, R | |
| 700 | 1 | _aPavone-Macaluso, M | |
| 700 | 1 | _aDebruyne, F | |
| 700 | 1 | _ade Pauw, M | |
| 700 | 1 | _aDalesio, O | |
| 700 | 1 | _aten Kate, F | |
| 773 | 0 |
_tThe Journal of urology _gvol. 132 _gno. 2 _gp. 258-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0022-5347(17)49582-6 _zAvailable from publisher's website |
| 999 |
_c6376736 _d6376736 |
||